FATE
Fate Therapeutics Inc
Price:  
1.53 
USD
Volume:  
8,541,915.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Relative Valuation

-2923.0%
Upside

As of 2025-02-19, the Relative Valuation of Fate Therapeutics Inc (FATE) is (43.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.53 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2923.0%.

The range of the Relative Valuation is (33.02) - (50.23) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.8x - 38.4x 28.6x
Forward P/E multiples 21.1x - 32.1x 26.6x
Fair Price (33.02) - (50.23) (43.19)
Upside -2258.2% - -3383.3% -2923.0%
1.53 USD
Stock Price
(43.19) USD
Fair Price

FATE Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 -0.91
2025-02-13 -0.81
2025-02-12 -0.80
2025-02-11 -0.77
2025-02-10 -0.80
2025-02-07 -0.81
2025-02-06 -0.89
2025-02-05 -0.91
2025-02-04 -0.84
2025-02-03 -0.81
2025-01-31 -0.83
2025-01-30 -0.88
2025-01-29 -0.84
2025-01-28 -0.83
2025-01-27 -0.88
2025-01-24 -0.85
2025-01-23 -0.86
2025-01-22 -0.86
2025-01-21 -0.84
2025-01-17 -0.81
2025-01-16 -0.80
2025-01-15 -0.84
2025-01-14 -0.80
2025-01-13 -0.82
2025-01-10 -0.94
2025-01-08 -1.07
2025-01-07 -1.12
2025-01-06 -1.19
2025-01-03 -1.15
2025-01-02 -1.14
2024-12-31 -1.05
2024-12-30 -1.04
2024-12-27 -1.03
2024-12-26 -1.04
2024-12-24 -1.06
2024-12-23 -1.06
2024-12-20 -1.07
2024-12-19 -1.06
2024-12-18 -1.08
2024-12-17 -1.20
2024-12-16 -1.28
2024-12-13 -1.17
2024-12-12 -1.23
2024-12-11 -1.39
2024-12-10 -1.46
2024-12-09 -1.74
2024-12-06 -1.69
2024-12-05 -1.52
2024-12-04 -1.64
2024-12-03 -1.68